Dr. Joseph Guettler heads clinical trial for knee cartilage damage implant: 5 things to know

Joseph Guettler, MD, is heading a clinical trial studying the use of a new tissue implant to treat knee cartilage damage, according to an Oakland Press Business report.

Advertisement

Here are five things to know:

 

1. Dr. Guettler is an orthopedic surgeon at Royal Oak, Mich.-based Beaumont Health System.

 

2. The NeoCart cartilage tissue implant, is made from the patient’s own cartilage cells.

 

3. Currently, microfracture surgery is considered the standard of care for most cases of knee cartilage injury.

 

4. The clinical trial will test whether the tissue implant will improve outcomes and recovery time for patients.

 

5. The Neocart implant is made by Histogenics which is sponsoring the clinical trial. Beaumont Health System is one of 31 clinical trial sites across the country.

 

More articles on orthopedics:
5 facts to note on Dr. David Levine—surgeon of Ranger’s Girardi & Staal
8 things to note about Dr. James Andrews — surgeon who saved Tyson Kidd’s career
Orthopedic surgeon to know: Dr. Bret Winter of Cheyenne Regional Medical Center

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in Orthopedic

Advertisement

Comments are closed.